Notice Number: NOT-AR-19-009
Release Date: September 14, 2018
Response Date: October 26, 2018
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is updating its Long-Range Plan to help guide the research it supports over the next five years. Public input on the topics to be included in the plan and suggestions regarding how to enhance the NIAMS research portfolio are critical initial steps in this effort. NIAMS leadership and staff will review and consider the comments as the Institute updates its Long-Range Plan.
Through this RFI, NIAMS invites feedback from researchers in academia and industry, health care professionals, patient advocates and health advocacy organizations, scientific or professional organizations, Federal agencies, and other interested members of the public. Organizations are strongly encouraged to submit a single response that reflects the views of their organization and membership as a whole.
Please provide your perspective on the following issues:
Research opportunities in the NIAMS Long-Range Plan for Fiscal Years (FY) 2015-2019 that should be modified because of progress over the past five years.
Emerging research needs and opportunities that should be added to the plan.
Cross-cutting scientific themes (e.g., pain, regenerative medicine) or research-related themes (e.g., innovation) common to all, or most, of the disease and tissue-specific topics (systemic rheumatic and autoimmune diseases, skin biology and diseases, bone biology and diseases, joint biology and diseases and orthopaedics, and muscle biology and diseases) within the NIAMS mission that should be included in the plan.
NIAMS also welcomes your general comments, including those regarding the extent to which the FY 2015-2019 Plan has guided and encouraged the field.
When commenting on a research need or opportunity, your comments can contain but are not limited to information pertaining to the following:
Description of the opportunity: Addressing an existing component of the FY 2015-2019 Plan that should be modified due to progress over the past five years, or a new opportunity for research not covered in the FY 2015-2019 Plan.
Rationale: The scientific evidence or clinical basis for the proposed change or addition and the anticipated impacts that accomplishments or advances related to this issue would have on the scientific community and human health.
How to Submit a Response
Responses to this RFI must be submitted electronically at https://grants.nih.gov/grants/rfi/rfi.cfm?ID=81.
Responses must be received by October 26, 2018.
Responses to this RFI are voluntary. Do not include any proprietary, classified, confidential, trade secret, or sensitive information in your response. The responses will be reviewed by NIAMS staff, and individual feedback will not be provided to any responder. NIAMS will use the information submitted in response to this RFI at its discretion and will not provide comments to any responder’s submission. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. The Government reserves the right to use any submitted information on public NIH websites, in reports, in summaries of the state of the science, in any possible resultant solicitation(s), grant(s), or cooperative agreement(s), or in the development of future funding opportunity announcements.
This RFI is for information and planning purposes only and shall not be construed as a solicitation, grant, or cooperative agreement, or as an obligation on the part of the Federal Government, the NIH, or individual NIH Institutes and Centers to provide support for any ideas identified in response to it. The Government will not pay for the preparation of any information submitted or for the Government’s use of such information. No basis for claims against the U.S. Government shall arise as a result of a response to this request for information or from the Government’s use of such information.
We look forward to your input and hope that you will share this RFI document with your colleagues.
Please direct all inquiries to:
Cindy Caughman, M.P.H.
Chief, Science Policy and Planning Branch
National Institute of Arthritis and Musculoskeletal and Skin Diseases